Skip to Main Content

Media

Members of our Executive Leadership Team discuss TDI. Learn what makes us unique, how we stand to impact the economy of NYC, and how we are changing the way that new drugs are developed across the Tri-I and beyond.


Laurie Glimcher, MD
Founder, Tri-I TDI
Stephen and Suzanne Weiss Dean, Weill Cornell Medicine, January 1, 2012 — May 31, 2016


Juan Harrison
Vice President, New Frontier Science
Takeda Pharmaceuticals International


Marc Tessier-Lavigne, PhD
Founder, Tri-I TDI
President, The Rockefeller University, March 16, 2011 — August 31, 2016


Michael A. Foley, PhD
Sanders Director
Tri-Institutional Therapeutics Discovery Institute


Craig B. Thompson, MD
Founder, Tri-I TDI
President & CEO, Memorial Sloan Kettering Cancer Center, November 2, 2010 — Present


TDI's Scientific Mission


TDI's Donor Support

 

Members of our Executive Leadership Team discuss TDI. Learn what makes us unique, how we stand to impact the economy of NYC, and how we are changing the way that new drugs are developed across the